window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 13, 2025

  • News
  • About Us
Contact Us

Cell Therapy

  • Cell & Gene Therapy,Clinical Trials,Rare Diseases,Regulatory Affairs

    First-in-class cell therapy for rare mitochondrial disorder gains FDA fast track

    FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]

    July 4, 2025
  • Cell & Gene Therapy,Clinical Trials,Drug Development,Oncology,Technology and platforms

    Galapagos CAR-T therapy shows strong results in relapsed indolent NHL

    Galapagos has announced promising results from Cohort 3 of its [...]

    June 27, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy

    Cherwell introduces Redipor TwistLock plate range to aid microbial environmental monitoring

    Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

    June 17, 2025
  • CDMOs & Manufacturing,Partnerships & Funding

    Chrysalis launches following cleanroom asset acquisition and strategic investment

    Chrysalis, a GMP-compliant space and service provider, has formally launched [...]

    June 16, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy

    MaxCyte and Ori Biotech integrate platforms to improve cell therapy manufacturing

    CD19 CAR CRISPR T cell workflow used to demonstrate shortened [...]

    June 12, 2025
  • Cell & Gene Therapy,Clinical Trials,Drug Development

    MaaT Pharma submits EMA application for Xervyteg in graft-versus-host disease

    MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]

    June 2, 2025
  • Cell & Gene Therapy,Market Access & Commercialization,Technology and platforms

    Limula secures US patent for automated cell therapy manufacturing tech

    Limula has confirmed the granting of a core patent in [...]

    June 2, 2025
  • Cell & Gene Therapy,Market Access & Commercialization,Technology and platforms

    Cellares brings automated CAR-T manufacturing to Japan with first IDMO Smart Factory

    Cellares and Mitsui Fudosan have announced plans to establish Japan’s [...]

    June 2, 2025
  • Artificial Intelligence,Cell & Gene Therapy,Partnerships & Funding,Patient Centricity

    Cellino and Karis Bio join forces to deliver personalized cell therapy in Asia-Pacific

    Cellino and Karis Bio have announced a strategic partnership to [...]

    June 2, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Drug Development

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 30, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno taps global CRO for next big step in pulmonary hypertension drug trial
    Categories: Clinical Trials, Drug Development, Rare Diseases
  • Eleva doses first volunteers with new therapy targeting rare kidney disease
    Categories: Biologics & Biosimilars, Clinical Trials, Drug Development, Rare Diseases
  • First-in-class cell therapy for rare mitochondrial disorder gains FDA fast track
    Categories: Cell & Gene Therapy, Clinical Trials, Rare Diseases, Regulatory Affairs
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top